Yan et al. found that the inhibition of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase isoform 3 (PFKFB3) attenuated oxaliplatin-induced autophagy and decreased the viability of colon cancer cells [23]. Here, PFKFB3 is linked to malignant colon neoplasm.